Sirius Investors

SVRA Stock: Savara Inc. Stock Price, Analysis & Insights

Get live svra stock price $3.42, comprehensive Savara Inc. stock analysis, charts, news, and expert forecast. Real-time svra stock data and investment insights.

3.42
1.59%Today
SVRASavara Inc. • NASDAQ Global Select • Healthcare
Market Cap
590.24M
Volume
806.15K
52W High
4.29
52W Low
1.89
Upgrade to Pro or Premium to access long-term historical data (3M, 6M, 1Y, 2Y, 5Y, 10Y, Max)

Company Overview

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Company Information

CEO
Matthew Pauls
Sector
Healthcare
Industry
Biotechnology
Employees
59

Contact Information

Address
Building III
Country
US

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 590.24M market capitalization
  • Trading Volume: 806.15K shares traded today
  • Price Range: 52-week range of $1.89 - $4.29
  • Exchange: Listed on NASDAQ Global Select

Financial Metrics

P/E Ratio:-6.70
EPS:$-0.51
Beta:0.46
Avg Volume:1.29M

Market Analysis for Savara Inc.

Savara Inc. (SVRA) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 590.24M, the company represents a significant player in its market. The stock is currently trading at $3.42 with a negativedaily change of 1.59%.

The company's 59 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -6.70, beta of 0.46, and 52-week price range from $1.89 to $4.29when evaluating investment opportunities.

Why Invest in Savara Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Global Select)
  • • Experienced leadership under Matthew Pauls
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.